Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Australian and New Zealand Journal of Medicine
|
February 1, 1987
Initial experience with a new fibrinolytic agent (APSAC) in patients with major pulmonary embolism
J H Bett, I H Bunce, J F Cade, et al.
Experimental and Molecular Pathology
|
December 1, 1975
Endotoxin-induced endothelial injury and repair. I. Endothelial cell turnover in the aorta of the rabbit
R G Gerrity, B A Caplan, M Richardson, et al.
Critical Care Medicine
|
February 1, 1991
Clinical evaluation of closed-loop control of blood pressure in seriously ill patients
S McKinley, J F Cade, R Siganporia, et al.
The Australian Journal of Experimental Biology and Medical Science
|
April 1, 1984
The potential bronchodilator action of verapamil
J F Cade, E A Clegg, R F Moulds, et al.
Thrombosis Research
|
September 15, 1984
A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation
J F Cade, M R Buchanan, B Boneu, et al.
Circulation
|
April 1, 1976
Heparin kinetics in venous thrombosis and pulmonary embolism
J Hirsh, W G van Aken, A S Gallus, et al.
Blood
|
January 1, 1980
Plasma concentrations of platelet-specific proteins correlated with platelet survival
D J Doyle, C N Chesterman, J F Cade, et al.
The American Review of Respiratory Disease
|
September 1, 1982
Herpes simplex virus from the lower respiratory tract in adult respiratory distress syndrome
D V Tuxen, J F Cade, M I McDonald, et al.
Thrombosis Research
|
October 1, 1985
Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth in vivo
B Boneu, M R Buchanan, J F Cade, et al.
Anaesthesia and Intensive Care
|
January 15, 2005
Blood usage in an Australian intensive care unit: have we met best practice goals?
D Farrar, M S Robertson, C J Hogan, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Australian and New Zealand Journal of Medicine
|
February 1, 1987
Initial experience with a new fibrinolytic agent (APSAC) in patients with major pulmonary embolism
J H Bett, I H Bunce, J F Cade, et al.
Experimental and Molecular Pathology
|
December 1, 1975
Endotoxin-induced endothelial injury and repair. I. Endothelial cell turnover in the aorta of the rabbit
R G Gerrity, B A Caplan, M Richardson, et al.
Critical Care Medicine
|
February 1, 1991
Clinical evaluation of closed-loop control of blood pressure in seriously ill patients
S McKinley, J F Cade, R Siganporia, et al.
The Australian Journal of Experimental Biology and Medical Science
|
April 1, 1984
The potential bronchodilator action of verapamil
J F Cade, E A Clegg, R F Moulds, et al.
Thrombosis Research
|
September 15, 1984
A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation
J F Cade, M R Buchanan, B Boneu, et al.
Circulation
|
April 1, 1976
Heparin kinetics in venous thrombosis and pulmonary embolism
J Hirsh, W G van Aken, A S Gallus, et al.
Blood
|
January 1, 1980
Plasma concentrations of platelet-specific proteins correlated with platelet survival
D J Doyle, C N Chesterman, J F Cade, et al.
The American Review of Respiratory Disease
|
September 1, 1982
Herpes simplex virus from the lower respiratory tract in adult respiratory distress syndrome
D V Tuxen, J F Cade, M I McDonald, et al.
Thrombosis Research
|
October 1, 1985
Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth in vivo
B Boneu, M R Buchanan, J F Cade, et al.
Anaesthesia and Intensive Care
|
January 15, 2005
Blood usage in an Australian intensive care unit: have we met best practice goals?
D Farrar, M S Robertson, C J Hogan, et al.
Page
of 9